Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children

Documenti analoghi

• A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
  di: Ndungu, F, et al.
  Pubblicazione: (2012)
• Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
  di: Olotu, A, et al.
  Pubblicazione: (2011)
• Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
  di: Olotu, A, et al.
  Pubblicazione: (2016)
• The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 E
  di: Ali, MS, et al.
  Pubblicazione: (2025)
• Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
  di: Olotu, A, et al.
  Pubblicazione: (2011)